# xenodata lab.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xenodata-lab

- Industry: Software
- Headquarters: Tokyo, Japan
- Website: www.xenodata-lab.com
- Total disclosed funding: $10M
- Latest round: Series C (Oct 9, 2024)
- Investors on record: 28

## About

Based in Japan, xenodata lab., Inc. specializes in developing artificial intelligence-driven economic forecasting solutions that enable businesses to make informed decisions through predictive analytics.Founded in 2016 and headquartered in Tokyo, Japan, xenodata lab., Inc. focuses on providing AI-based forecasting solutions. In October 2024, xenodata lab., Inc. raised an undisclosed amount in series C funding from Okasan Capital Partners and Carta Ventures. This round was part of a larger JPY 320 million series C equity and venture debt funding. The CEO, Yojiro Seki, has led the company through its various growth phases without any noted pivots or changes in business strategy.Xenodata Lab, through its flagship product xenoBrain, offers an advanced economic forecasting platform that leverages artificial intelligence to provide robust predictive analytics for businesses across various sectors. The platform delivers performance forecasts for approximately 500,000 unlisted companies across 20,000 industry categories, enabling clients to make data-driven decisions regarding sales, demand, and market trends. By focusing on generating actionable insights, xenoBrain aids organizations in strategic planning and operational optimization, primarily targeting markets in Japan and other regions requiring sophisticated forecasting capabilities.Xenodata Lab generates revenue through a subscription-based model, providing clients with access to its xenoBrain platform. Clients, including corporations and industry players, pay a fee for utilizing predictive analytics services aimed at economic forecasting. The revenue structure accommodates both individual subscriptions and B2B partnerships, ensuring a steady revenue stream by aligning client interests with the effectiveness of the forecasting tools provided.In October 2024, xenodata lab., Inc. secured additional venture debt to enhance its development and sales capabilities. The funding will be allocated towards hiring engineers and sales personnel, enabling the company to strengthen its operational structure. The company plans to use the October 2024 funding to strengthen its development and sales structure by hiring engineers and sales personnel.

## Funding rounds

- Series C, Oct 9, 2024 — SBI Okasan Alternative Investment, Carta Ventures
- Series E, Aug 25, 2023, $1.2M — Sagin Capital & Consulting, ibis Capital Partners, Kagawa Securities, OKB Capital, Meinan Management Capital, AirTrip
- Series B, Mar 25, 2019, $6.2M — Dai-ichi Life Insurance, Mitsui Sumitomo Insurance Venture Capital, Shizuoka Capital, Yokohama Capital, DBJ Capital, Venture Labo Investment, Keio Innovation Initiative, freebit investment, Teikoku Databank, Ltd., Yamanashi Chugin Management Consulting, Jiji Press, Ltd., Japan Investment Adviser, Naito Securities Co., Ltd.
- Series A, Nov 22, 2017, $2.2M — MUFG Bank, SMBC Venture Capital, Mizuho Capital, Tokai Tokyo Investment, DBJ Capital, Teikoku Databank, Ltd., Okasan Securities Co., Ltd., au Kabucom Securities Co., Ltd.
- Seed, Feb 6, 2017, $0.5M — MUFG Bank, Mitsubishi UFJ Capital, Teikoku Databank, Ltd., au Kabucom Securities Co., Ltd.

## Investors

- MUFG Bank — Seed, Series A
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Seed
- Teikoku Databank, Ltd. — Seed, Series A, Series B
- au Kabucom Securities Co., Ltd. — Seed, Series A
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series A
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series A
- Tokai Tokyo Investment (https://capitalatlas.ai/funds/tokai-tokyo-investment) — Series A
- DBJ Capital (https://capitalatlas.ai/funds/dbj-capital) — Series A, Series B
- Okasan Securities Co., Ltd. — Series A
- Dai-ichi Life Insurance — Series B
- Mitsui Sumitomo Insurance Venture Capital (https://capitalatlas.ai/funds/mitsui-sumitomo-insurance-venture-capital) — Series B
- Shizuoka Capital (https://capitalatlas.ai/funds/shizuoka-capital) — Series B
- Yokohama Capital (https://capitalatlas.ai/funds/yokohama-capital) — Series B
- Venture Labo Investment (https://capitalatlas.ai/funds/venture-labo-investment) — Series B
- Keio Innovation Initiative (https://capitalatlas.ai/funds/keio-innovation-initiative) — Series B
- freebit investment (https://capitalatlas.ai/funds/freebit-investment) — Series B
- Yamanashi Chugin Management Consulting (https://capitalatlas.ai/funds/yamanashi-chugin-management-consulting) — Series B
- Jiji Press, Ltd. — Series B
- Japan Investment Adviser (https://capitalatlas.ai/funds/japan-investment-adviser) — Series B
- Naito Securities Co., Ltd. — Series B
- Sagin Capital & Consulting (https://capitalatlas.ai/funds/sagin-capital-consulting) — Series E
- ibis Capital Partners (https://capitalatlas.ai/funds/ibis-capital-partners) — Series E
- Kagawa Securities — Series E
- OKB Capital (https://capitalatlas.ai/funds/okb-capital) — Series E
- Meinan Management Capital (https://capitalatlas.ai/funds/meinan-management-capital) — Series E
- AirTrip — Series E
- SBI Okasan Alternative Investment (https://capitalatlas.ai/funds/sbi-okasan-alternative-investment) — Series C
- Carta Ventures (https://capitalatlas.ai/funds/carta-ventures) — Series C